Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F16%3A10323713" target="_blank" >RIV/00064203:_____/16:10323713 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/16:10323713
Výsledek na webu
<a href="http://dx.doi.org/10.1002/pbc.25855" target="_blank" >http://dx.doi.org/10.1002/pbc.25855</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/pbc.25855" target="_blank" >10.1002/pbc.25855</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis
Popis výsledku v původním jazyce
BackgroundThe risk of early death (ED) by bleeding/leukostasis is high in patients with AML with hyperleukocytosis (>100,000/l). Within the pediatric AML-BFM (Berlin-Frankfurt-Munster) 98/04 studies, emergency strategies for these children included exchange transfusion (ET) or leukapheresis (LPh). Risk factors for ED and interventions performed were analyzed. PatientsTwo hundred thirty-eight of 1,251 (19%) patients with AML presented with hyperleukocytosis; 23 of 1,251 (1.8%) patients died of bleeding/leukostasis. ResultsED due to bleeding/leukostasis was highest at white blood cell (WBC) count >200,000/l (14.3%). ED rates were even higher (20%) in patients with FAB (French-American-British) M4/M5 and hyperleukocytosis >200,000/l. Patients with WBC >200,000/l did slightly better with ET/LPh compared to those without ET/LPh (ED rate 7.5% vs. 21.2%, P = 0.055). Multivariate WBC >200,000/l was of strongest prognostic significance for ED (P((2)) <0.0001). ConclusionOur data confirm the high risk of bleeding/leukostasis in patients with hyperleukocytosis. ET/LPh shows a trend toward reduced ED rate due to bleeding/leukostasis and is recommended at WBC >200,000/l, and in FAB M4/M5 even at lower WBC.
Název v anglickém jazyce
Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis
Popis výsledku anglicky
BackgroundThe risk of early death (ED) by bleeding/leukostasis is high in patients with AML with hyperleukocytosis (>100,000/l). Within the pediatric AML-BFM (Berlin-Frankfurt-Munster) 98/04 studies, emergency strategies for these children included exchange transfusion (ET) or leukapheresis (LPh). Risk factors for ED and interventions performed were analyzed. PatientsTwo hundred thirty-eight of 1,251 (19%) patients with AML presented with hyperleukocytosis; 23 of 1,251 (1.8%) patients died of bleeding/leukostasis. ResultsED due to bleeding/leukostasis was highest at white blood cell (WBC) count >200,000/l (14.3%). ED rates were even higher (20%) in patients with FAB (French-American-British) M4/M5 and hyperleukocytosis >200,000/l. Patients with WBC >200,000/l did slightly better with ET/LPh compared to those without ET/LPh (ED rate 7.5% vs. 21.2%, P = 0.055). Multivariate WBC >200,000/l was of strongest prognostic significance for ED (P((2)) <0.0001). ConclusionOur data confirm the high risk of bleeding/leukostasis in patients with hyperleukocytosis. ET/LPh shows a trend toward reduced ED rate due to bleeding/leukostasis and is recommended at WBC >200,000/l, and in FAB M4/M5 even at lower WBC.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Pediatric Blood and Cancer
ISSN
1545-5009
e-ISSN
—
Svazek periodika
63
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
6
Strana od-do
640-645
Kód UT WoS článku
000370497100012
EID výsledku v databázi Scopus
2-s2.0-84959512935